Study Questions Necessity of Early Hysteroscopy After Suction D&C Despite Early Detection of Intrauterine Lesions

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-07-19 15:30 GMT   |   Update On 2024-07-19 15:30 GMT
Advertisement

Taiwan: A recent randomized controlled trial has shed light on the efficacy of early office hysteroscopy in preventing intrauterine adhesions after abortion.

The study, published in BMC Women's Health, suggests that early office hysteroscopy following well-monitored suction dilatation and curettage (D&C) with intraoperative sonography may not be necessary. Furthermore, early hysteroscopy allowed early detection of intrauterine lesions (IUA).

Advertisement

"It's important to highlight that while the pregnancy outcomes showed a positive trend in the early hysteroscopy group, there were no statistically significant differences observed," the researchers wrote.

Intrauterine adhesions, commonly known as Asherman's syndrome, are a challenging clinical problem in reproductive infertility. The most common causes are abortions and intrauterine surgery. Kuo-Chung Lan, Kaohsiung Medical University, Kaohsiung, Taiwan, and colleagues aimed to investigate whether early second-look office hysteroscopy can prevent IUA.

To explore the efficacy of early office hysteroscopy after first-trimester induced abortion suction D&C and to further analyze fertility outcomes, the researchers designed a single-center, prospective, two-armed, randomized controlled trial. It recruited women aged 20–45 years undergoing suction D&C and desiring to conceive.

Sixty-six women were enrolled between 2019 and 2022, of whom 33 were allocated to group A (early hysteroscopy intervention). Women in intervention group A were scheduled for two hysteroscopies (early and late), while women in group B underwent only one late hysteroscopy, six months after the suction D&C.

The primary outcome was the rate of intrauterine adhesions, evaluated through office hysteroscopy six months after the artificial abortion. Secondary outcomes included menstrual volume and duration, as well as fertility outcomes.

The study led to the following findings:

· In intervention group A, 31 women underwent the first hysteroscopy examination, and 15 completed the second.

· In group B (late hysteroscopy intervention, 33 patients), 16 completed the hysteroscopic exam six months after an artificial abortion.

· Twenty-one women did not receive late hysteroscopy due to pregnancy.

· The IUA rate was 16.1% (5/31) at the first hysteroscopy in group A, and no IUA was detected during late hysteroscopy.

· Neither group showed statistically significant differences in the follow-up pregnancy and live birth rates.

The researchers concluded that early hysteroscopy after suction D&C can identify intrauterine lesions. Intrauterine adhesions detected early through hysteroscopy may resolve by the time of later examinations, becoming insignificant for future pregnancies. While pregnancy outcomes showed a positive trend in the early hysteroscopy group, we found no statistically significant differences.

"Further studies could investigate the role of hysteroscopy and hyaluronic gel following multiple suction D&Cs and/or medical abortions. This preliminary report may catalyze others to explore and validate these findings," they wrote.

Reference:

Tsai, NC., Hsiao, YY., Su, YT. et al. The efficacy of early office hysteroscopy in preventing intrauterine adhesions after abortion: a randomized controlled trial. BMC Women's Health 24, 400 (2024). https://doi.org/10.1186/s12905-024-03247-0


Tags:    
Article Source : BMC Women's Health

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News